AMRZ stock forecast, quote, news & analysis

Key Takeaways

• Amrize shares have declined approximately 7% over the past 30 days, trading near $49.25 as of late July 2026, well below the 52-week high of $65.94.
• Wall Street maintains a consensus Moderate Buy rating with an average price target of roughly $63, implying over 27% potential upside from current levels.
• Rising petrochemical input costs tied to geopolitical disruptions are weighing on the Building Envelope (roofing) segment, prompting Truist Financial to downgrade the stock to Hold in early July.
• The company continues to execute on strategic growth initiatives, including the recently announced acquisition of Rapid Redi-Mix in Dallas-Fort Worth and the Saint-Constant cement plant modernization in Quebec.
• Q2 2026 earnings, set for release on August 6, represent the next critical catalyst as investors assess pricing power, margin trends, and demand across infrastructure, commercial, and residential end markets.

Current Market Snapshot

Amrize Ltd. (NYSE: AMRZ) entered the second half of 2026 under a mix of analyst optimism and near-term operational headwinds. The stock closed at $49.25 on July 24, hovering near the lower end of its 50-day trading range and roughly 25% below its 52-week peak. Trading volumes have remained consistent with the three-month average, reflecting steady institutional interest despite the pullback. The building materials sector has faced broader pressure from elevated energy costs and uncertainty around the pace of government infrastructure spending, while Amrize-specific concerns around roofing segment margins have added a layer of caution. Still, the majority of sell-side analysts covering the name have retained constructive ratings, pointing to the company's market-leading North American footprint, strong cement and aggregates reserves, and a multi-year capital investment program as reasons for longer-term conviction.

Amrize (AMRZ) Business Overview and Competitive Position

Amrize is a North American building materials powerhouse, formed through the 100% spin-off from Holcim in June 2025. Headquartered in Chicago, Illinois, with a registered office in Zug, Switzerland, the company operates more than 1,000 sites across every U.S. state and Canadian province, employing roughly 19,000 people. Amrize is organized into two segments: Building Materials, which covers cement, aggregates, ready-mix concrete, and asphalt; and Building Envelope, which includes advanced roofing and wall systems, insulation, waterproofing, adhesives, and sealants. The company is the largest cement producer in North America and the second-largest commercial roofing provider on the continent. With nearly 5.5 billion tons of aggregate reserves and 2.1 billion tons of cement reserves at end-2024 — representing decades of supply — Amrize benefits from exceptionally high barriers to entry. In 2025, the company generated approximately $11.8 billion in revenue and posted adjusted EBITDA of roughly $3.0 billion. Its 2026 guidance targets 4% to 6% revenue growth and 8% to 11% adjusted EBITDA growth, supported by the ASPIRE cost-savings program, capacity expansions, and strategic bolt-on acquisitions.

Recent Developments Driving AMRZ

Several developments have shaped investor sentiment over the past month. On July 20, Amrize announced an agreement to acquire Rapid Redi-Mix LLC, a concrete producer in the Dallas-Fort Worth metro area, complementing its earlier acquisition of PB Materials in West Texas and the ongoing Midlothian cement plant expansion. The deal underscores Amrize's commitment to vertically integrating in high-growth Sun Belt markets. Earlier in July, the company broke ground on a modernization project at its Saint-Constant cement plant in Quebec, a 300,000-ton capacity expansion supported in part by Canadian government low-carbon funding.

On the analyst front, early July brought mixed signals. Truist Financial downgraded Amrize to Hold from Buy and slashed its price target from $65 to $48, citing margin erosion in commercial roofing driven by surging petrochemical input costs — particularly MDI, which spiked as much as 73% following Iran-related supply disruptions and force majeure declarations from Dow and Covestro. Wells Fargo lowered its target from $65 to $58 but maintained an Overweight rating, while J.P. Morgan held its Buy rating and raised its target from $68 to $70. Insiders have continued to show confidence: CEO Jan Jenisch and other senior executives purchased shares in May and June at prices near or above current levels.

Trending AI Robots

For investors seeking data-driven approaches to navigate evolving market conditions, Tickeron's Trending AI Robots page offers a curated view of top-performing AI-powered trading bots. Tickeron hosts hundreds of automated trading bots that actively monitor thousands of tickers across equity markets, but only those demonstrating the strongest recent performance and strategic relevance appear in this featured section. These bots span a wide range of trading strategies, time horizons, and risk profiles — from short-term momentum-based models to longer-term value-oriented approaches — each backed by transparent performance metrics. Traders and investors can explore the page to identify AI-driven strategies aligned with their own market outlook and portfolio goals.

2026 Outlook and What Investors Should Watch

The second half of 2026 presents a pivotal period for Amrize. The immediate focus is the Q2 earnings release on August 6, where management's commentary on pricing realization — particularly in cement and roofing — will be closely scrutinized. Bernstein's pre-earnings check in late June indicated that Amrize passed through cement price increases in April and implemented fuel surcharges, with confidence in achieving low single-digit cement pricing for the full year and mid single-digit growth in aggregates. However, the trajectory of price-cost spreads in the Building Envelope segment remains the key swing factor, with management expecting a low single-digit headwind in the first half before turning neutral in Q3 and positive in Q4.

Beyond earnings, investors should monitor the pace of federal infrastructure spending, the trajectory of energy and petrochemical input costs, and the integration progress of recent acquisitions including PB Materials and Rapid Redi-Mix. The $1 billion share repurchase program authorized through May 2027 provides a potential floor for shares. Competitive dynamics also warrant attention: Kingspan's entry into the U.S. non-residential roofing market with two new plants represents a longer-term threat that could pressure pricing into 2027. With a P/E ratio near 23.4 and consensus analyst price targets clustering in the $58 to $70 range, the stock's near-term direction will likely hinge on whether Q2 results confirm that margin pressures are manageable and that the company's growth investments are translating into sustainable earnings momentum.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations